# Treatment of IgA Nephropathy According to Renal Lesions

> **NCT03188887** · PHASE3 · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 62 (actual)

## Conditions studied

- IgA Nephropathy

## Interventions

- **DRUG:** corticotherapy
- **DRUG:** Renin Angiotensin system (RAS) blockade or Inhibitors of sodium glucose transporter 2 (SGLT2i)

## Key facts

- **NCT ID:** NCT03188887
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-20
- **Primary completion:** 2024-01-12
- **Final completion:** 2024-01-12
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2025-11-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03188887

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03188887, "Treatment of IgA Nephropathy According to Renal Lesions". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03188887. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*